homocysteine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadet, JL; Cutler, RG; Duan, W; Kruman, II; Ladenheim, B; Mattson, MP | 1 |
| Miller, JW | 1 |
| Imamura, K; Nakashima, K; Nakaso, K; Takeshima, T | 1 |
1 review(s) available for homocysteine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Homocysteine, folate deficiency, and Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Mice; Parkinson Disease; Risk Factors | 2002 |
2 other study(ies) available for homocysteine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biomarkers; Brain; Cell Survival; Corpus Striatum; Diet; Dopamine; Drug Synergism; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Iron; Male; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; Neurons; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Rotenone; Tumor Cells, Cultured | 2002 |
Homocysteine is toxic for dopaminergic neurons in primary mesencephalic culture.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antipsychotic Agents; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Embryo, Mammalian; Female; Homocysteine; Mesencephalon; Microtubule-Associated Proteins; Neurons; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Tyrosine 3-Monooxygenase | 2007 |